Gone Vegan.
Capsugel® HPMC portfolio

Contact us: solutions.emea@lonza.com  |   www.capsugel.com

Non-animal based alternative   |   Broadest HPMC offering  |  Capsugel® quality and performance

Lonza makes no warranties or representations of accuracy or completeness. All trademarks belong to Lonza or its affiliates.

Vcaps® Plus

The gold standard in HPMC capsules

Properties

  • HPMC only Capsules
  • No gelling agents
  • Improved physical and operational features to match the needs of the pharmaceutical industry

01

Dissolution profile

  • pH-independent performance 
  • Independent of ionic strength

02

Key advantages

  • Great visual appearance
  • Low-moisture content suitable for moisture-sensitive ingredients
  • Great machinability

03

More on Vcaps® plus

Vcaps® Enteric

 Right on target

Proven Properties

  • Intrinsically enteric capsule 
  • Improving tolerability of API’s that cause gastric-irritation 
  • API protection against degradation in the gastric environment
  • Achieving targeted release in the small intestine

01

In vitro dissolution test

  • Complies with pharmacopoeial requirements for delayed release
  • Robust enteric release 
  • Immediate and full disintegration at pH 6.8

02

Key advantages

  • Saves development time
  • No coating needed
  • High API protection

03

More on Vcaps® Enteric

Go to article: Home | Rise of The Tech GiantsGo to article: The Pharma Industry BriefingGo to article: EditorialGo to article: NSF Go to article: ContentsGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: NewsGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: DaiichiGo to article: Is China the next great hope for the pharma industry?Go to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: Antimicrobial resistance: is pharmaceutical pollution creating superbugs?Go to article: MedelpharmGo to article: Why is it so hard to reproduce medical research resultsGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Pat-INFORMED: the solution to drug patent procurement issues?Go to article: TSS ABGo to article: Will tech giants like Amazon and Google change the pharma sector forever? Go to article: Capsugel Company InsightGo to article: CapsugelGo to article: Unreal Engine: from gaming to ground-breaking cures Go to article: QualiMetriXGo to article: Are pharma supply chains ready for the next major disruption?Go to article: SensitechGo to article: Can blockchain stem the tide of counterfeit drugs in India? Go to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: EventsGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Event: Outsourcing in Clinical Trials East Asia Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Event: Pharmpack EuropeGo to article: Next issueGo to article: PJC Company InsightGo to article: Corbion PuracGo to article: Abiogen PharmaGo to article: BEAGo to article: Unither PharmaceuticalsGo to article: EvolveGo to article: Cargolux Company InsightGo to article: CargoluxGo to article: LaudaGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: G.F.Go to article: Phoenix Company InsightGo to article: PhoenixGo to article: EcocoolGo to article: B Medical SystemsGo to article: B & W Tek Go to article: Miami International AirportGo to article: PharmasolGo to article: Cryo StoreGo to article: AlpexGo to article: AECO Telecom & Security Systems